Author

Raquel Hladun

Universitat Autònoma de BarcelonaORCID 0000-0002-3191-1750Unclaimed ORCID profile · follow to get notified of new preprints

Biology Disciplines

Click to filter author papers

Cancer Biology· 1 Genetic & Genomic Medicine· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:benchmarking· 1 Assay:bulk RNA-seq· 1 Research Focus:cancer & tumor microenvironment· 1 Research Focus:drug response / drug discovery· 1 Approach:experimental assay· 1 Organism:human· 1 Organism:mouse· 1 Research Focus:perturbation response prediction· 1

Frequent Co-Authors

Aroa SorianoiD· 2 shared Amelie S. WenziD· 1 shared Asbleidy Carolina TorresiD· 1 shared Gabriel Gallo-OlleriD· 1 shared Gabriela GuilléniD· 1 shared Guillem PonsiD· 1 shared James CreedeniD· 1 shared Jordi Carreras PuigvertiD· 1 shared

Activity by Year

2024-2026 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 31 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersGenetic & Genomic Medicine

Aroa SorianoORCID

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

Evaluation of AI-assisted summarisation of tertiary clinical genomics reports: results of the QNOMX-VHIR-CPSP-001 Phase 1 study

James Creeden, Marcus Olivecrona, Nuria Benavent, Raquel Hladun, Lorena Valero‐Arrese, Asbleidy Carolina Torres, Aroa Soriano

This study evaluates AI-generated summaries of pediatric cancer genomics reports, finding they are non-inferior to manual summaries in content and presentation.

medRxiv · Sep 11, 2026 · PreprintGenetic & Genomic Medicine

Combined inhibition of MDM2 and PARP lead to a synergistic anti-tumoral response in p53 wild-type rhabdomyosarcoma models

Guillem Pons, Patricia Zarzosa, Gabriel Gallo-Oller, Amelie S. Wenz, Maris Lapins, Lia García-Gilabert, Júlia Sansa-Girona, Natalia Navarro, Miguel F. Segura, Aroa Soriano, Gabriela Guillén, Raquel Hladun, Josep Sánchez de Toledo, Soledad Gallego, Jordi Carreras Puigvert, , Josep M Roma

This study shows that combining MDM2 and PARP inhibitors synergistically inhibits p53 wild-type rhabdomyosarcoma growth in vitro and in vivo.

bioRxiv · Dec 3, 2024 · PreprintCancer Biology